We serve as outside general counsel for HigherDOSE, a growth stage wellness product and services company. We advise the company on corporate entity structure; capital raising; equity incentives; intellectual property protection, including defense of patent infringement claims and counseling on patentability; data privacy, including CCPA and GDPR compliance; FDA compliance with respect to advertising claims; commercial contracts; waivers; product safety and employment matters.
Outside General Counsel for Growth Stage Wellness Company
You Also May Be Interested In:
Representation of Mallinckrodt Pharmaceuticals, a global pharmaceutical manufacturer, in numerous cases in courts across Tennessee, Kentucky, and Virginia
Representation of Tivity Health in a syndicated loan transaction providing the company with a $400 million senior secured term loan B facility and a $100 million senior secured revolving facility.
Lead Counsel to POINT Biopharma Inc. in its Proposed SPAC Business Combination with Research Alliance Corp. I
Lead Counsel to POINT Biopharma Inc. in connection with its proposed SPAC business combination with Therapeutics Acquisition Corp. d/b/a Research Alliance Corp. I (Nasdaq: RACA), a special purpose acquisition company, sponsored by RA Capital Management. Upon closing, the combined company will be named POINT Biopharma Global Inc. and is expected to be listed on Nasdaq under the ticker symbol “PNT”.